Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning: A Pharmacological fMRI Study

NCT01161277 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01161277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01161277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning: A Pharmacological fMRI Study
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
June 30, 2011
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, schizophrenia